Cellular dehydrogenases provide the reducing activity that converts yellow XTT into orange, water-soluble formazan. Because this reaction depends on activity in living cells, the resulting color links the optical signal to cellular viability and metabolism. Measuring absorbance therefore gives researchers a quantitative way to compare how treatments alter cell-associated metabolic activity across experimental conditions.
An absorbance reading reflects both the number of viable cells and the metabolic activity of those cells, rather than serving as a direct count of cell number alone. This distinction matters when interpreting treatment results: a change in signal may indicate altered viability, altered metabolism, or both. Comparisons are most informative when experimental conditions are evaluated consistently.
Compared with radioactive measurement formats, the XTT assay provides a nonradioactive approach with a straightforward optical readout. The water-soluble orange formazan product can be measured by spectrophotometry, connecting the biochemical reaction to a numerical signal. This combination is useful when studies need quantitative comparisons of treatment responses in cancer research, pharmacology, toxicology, or screening.
Researchers expose cells to the treatments being studied, allow the cellular reaction with XTT to generate the colored formazan product, and measure the resulting absorbance with a spectrophotometer. They then compare optical signals across conditions to estimate relative changes in viability or metabolic activity. This workflow supports direct evaluation of treatment effects within the chosen experimental design.
The assay can reveal whether a drug or other compound changes cell-associated metabolic activity and estimated viability. Researchers can use differences in absorbance to compare treatment conditions, investigate cytotoxic effects, or assess patterns consistent with changes in cell proliferation. These measurements support compound evaluation in experiments where treatment response is the primary outcome.
Its quantitative optical readout supports studies that compare how cells respond to different treatments, while its nonradioactive format suits routine biomedical experiments. In medicine-related research, applications include cancer investigations, pharmacology, toxicology, and compound screening. The assay therefore helps connect cellular metabolic responses with questions about treatment effects and potential cytotoxicity.